Colgate-Palmolive (NYSE:CL) Price Target Raised to $91.00 at Jefferies Financial Group

Colgate-Palmolive (NYSE:CL) had its price objective lifted by Jefferies Financial Group from $85.00 to $91.00 in a report published on Monday,Benzinga reports. Jefferies Financial Group currently has a hold rating on the stock.

Other research analysts have also issued reports about the company. Piper Sandler lifted their target price on Colgate-Palmolive from $88.00 to $96.00 and gave the stock an “overweight” rating in a report on Friday. UBS Group raised their price target on Colgate-Palmolive from $90.00 to $93.00 and gave the stock a “buy” rating in a research report on Wednesday, January 14th. Royal Bank Of Canada upgraded Colgate-Palmolive from a “sector perform” rating to an “outperform” rating and set a $88.00 price objective for the company in a research report on Tuesday, December 9th. Wells Fargo & Company increased their target price on Colgate-Palmolive from $86.00 to $94.00 and gave the stock an “equal weight” rating in a research note on Sunday. Finally, Deutsche Bank Aktiengesellschaft raised their target price on shares of Colgate-Palmolive from $83.00 to $90.00 and gave the stock a “hold” rating in a report on Monday. Eleven research analysts have rated the stock with a Buy rating and six have given a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average price target of $94.13.

Colgate-Palmolive Stock Up 1.6%

Shares of NYSE CL opened at $91.75 on Monday. Colgate-Palmolive has a 52-week low of $74.54 and a 52-week high of $100.18. The company has a debt-to-equity ratio of 5.90, a quick ratio of 0.27 and a current ratio of 0.42. The stock has a market cap of $73.96 billion, a P/E ratio of 35.02, a P/E/G ratio of 6.09 and a beta of 0.29. The firm has a 50 day moving average price of $81.02 and a 200 day moving average price of $81.37.

Colgate-Palmolive (NYSE:CL) last posted its earnings results on Friday, January 30th. The company reported $0.95 earnings per share for the quarter, topping the consensus estimate of $0.91 by $0.04. Colgate-Palmolive had a net margin of 10.45% and a return on equity of 353.72%. The company had revenue of $5.23 billion for the quarter, compared to analyst estimates of $5.13 billion. During the same period last year, the business posted $0.91 earnings per share. The business’s revenue for the quarter was up 5.8% compared to the same quarter last year. Analysts expect that Colgate-Palmolive will post 3.75 EPS for the current year.

Colgate-Palmolive Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, February 13th. Stockholders of record on Wednesday, January 21st will be paid a dividend of $0.52 per share. This represents a $2.08 annualized dividend and a dividend yield of 2.3%. The ex-dividend date of this dividend is Wednesday, January 21st. Colgate-Palmolive’s dividend payout ratio (DPR) is currently 79.39%.

Institutional Inflows and Outflows

Large investors have recently added to or reduced their stakes in the business. Westside Investment Management Inc. lifted its position in Colgate-Palmolive by 85.5% during the 2nd quarter. Westside Investment Management Inc. now owns 282 shares of the company’s stock worth $26,000 after buying an additional 130 shares in the last quarter. Maseco LLP acquired a new stake in shares of Colgate-Palmolive in the fourth quarter valued at about $27,000. Copia Wealth Management bought a new stake in Colgate-Palmolive during the third quarter worth about $29,000. Vermillion & White Wealth Management Group LLC boosted its position in Colgate-Palmolive by 86.1% during the second quarter. Vermillion & White Wealth Management Group LLC now owns 335 shares of the company’s stock valued at $30,000 after purchasing an additional 155 shares during the last quarter. Finally, Cloud Capital Management LLC bought a new position in Colgate-Palmolive in the third quarter valued at approximately $30,000. Institutional investors and hedge funds own 80.41% of the company’s stock.

Colgate-Palmolive News Roundup

Here are the key news stories impacting Colgate-Palmolive this week:

• Positive Sentiment: Large-cap brokers raised targets/ratings — Bank of America moved its target to $100 and kept a Buy rating (about ~9% upside), signaling confidence in the company’s growth drivers. Bank of America raises PT to $100
• Positive Sentiment: Evercore lifted its target to $100 and set an Outperform rating, another high-profile shop adding upside to consensus. Evercore raises PT to $100
• Positive Sentiment: JPMorgan raised its price target to $97 and put CL at Overweight, adding institutional weight behind the post-earnings view. JPMorgan raises PT to $97
• Positive Sentiment: Colgate reported Q4 results that beat estimates (EPS $0.95 vs. $0.91 expected; revenue $5.23B vs. $5.13B expected) and organic sales growth, which prompted analysts to boost forecasts. Earnings strength is the primary catalyst for the upgrades. Analysts Boost Forecasts After Q4 Beat
• Positive Sentiment: Sell-side commentary (TD Cowen, Bank of America research notes) emphasizes premiumization, emerging-market strength and pet nutrition as multi-year growth levers supporting Buy ratings. Analyst thematic support
• Neutral Sentiment: Jefferies raised its target modestly to $91 but keeps a Hold rating; the new target is near the current price, implying limited near-term upside. Jefferies raises PT to $91 (Hold)
• Neutral Sentiment: Deutsche Bank raised its target to $90 and remains a Hold, another signal that some shops see less immediate upside despite the beat. Deutsche Bank raises PT to $90
• Negative Sentiment: Press coverage highlights lingering consumer uncertainty that could pressure volumes/mix going forward, a reminder that macro headwinds remain despite the beat. Consumer uncertainty clouds outlook

Colgate-Palmolive Company Profile

Colgate-Palmolive Company is a global consumer products company with a long history in household and personal care categories. The business traces its roots to the early 19th century and has evolved into a multinational manufacturer and marketer of everyday consumer goods focused on health, hygiene and home care.

The company’s core activities center on oral care, personal care, home care and pet nutrition. Its product portfolio includes toothpaste, toothbrushes and mouthwash in oral care; soaps, body washes and deodorants in personal care; dishwashing liquids, surface cleaners and other household products in home care; and scientifically formulated pet foods under its pet nutrition business.